BHARAT PARENTERALS
|
BHARAT PARENTERALS Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 38.82 | 42.14 | 36.89 | 35.27 | 45.90 |
| CEPS(Rs) | 49.82 | 52.27 | 48.43 | 45.80 | 56.17 |
| DPS(Rs) | 1.00 | 0.75 | - | - | - |
| Book NAV/Share(Rs) | 367.05 | 329.94 | 287.72 | 250.47 | 214.92 |
| Tax Rate(%) | 26.65 | 24.35 | 24.90 | 25.20 | 24.75 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 10.30 | 8.52 | 11.79 | 10.63 | 13.17 |
| EBIT Margin(%) | 12.26 | 13.74 | 12.32 | 11.74 | 15.83 |
| Pre Tax Margin(%) | 10.87 | 12.73 | 11.77 | 11.42 | 15.44 |
| PAT Margin (%) | 7.98 | 9.63 | 8.84 | 8.54 | 11.62 |
| Cash Profit Margin (%) | 10.24 | 11.94 | 11.61 | 11.09 | 14.22 |
| Performance Ratios | |||||
| ROA(%) | 6.50 | 9.25 | 10.29 | 10.40 | 14.88 |
| ROE(%) | 11.18 | 13.65 | 13.76 | 15.16 | 23.92 |
| ROCE(%) | 13.02 | 16.62 | 17.59 | 19.80 | 31.68 |
| Asset Turnover(x) | 0.81 | 0.96 | 1.16 | 1.22 | 1.28 |
| Sales/Fixed Asset(x) | 3.63 | 3.44 | 3.35 | 3.80 | 4.37 |
| Working Capital/Sales(x) | 5.62 | 3.82 | 2.34 | 2.23 | 3.21 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.28 | 0.29 | 0.30 | 0.26 | 0.23 |
| Receivable days | 162.49 | 134.17 | 106.98 | 115.35 | 118.81 |
| Inventory Days | 59.46 | 42.32 | 32.72 | 38.67 | 39.35 |
| Payable days | 116.50 | 93.53 | 65.32 | 93.74 | 92.14 |
| Valuation Parameters | |||||
| PER(x) | 28.91 | 7.97 | 9.25 | 9.50 | 3.09 |
| PCE(x) | 22.53 | 6.43 | 7.05 | 7.32 | 2.52 |
| Price/Book(x) | 3.06 | 1.02 | 1.19 | 1.34 | 0.66 |
| Yield(%) | 0.09 | 0.22 | - | - | - |
| EV/Net Sales(x) | 2.89 | 1.07 | 0.98 | 0.99 | 0.32 |
| EV/Core EBITDA(x) | 17.83 | 5.72 | 5.71 | 5.98 | 1.74 |
| EV/EBIT(x) | 21.12 | 6.69 | 6.99 | 7.27 | 2.03 |
| EV/CE(x) | 2.47 | 0.75 | 0.95 | 1.03 | 0.38 |
| M Cap / Sales | 2.57 | 0.89 | 0.93 | 0.94 | 0.36 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 16.60 | 2.81 | 4.10 | -10.01 | 3.02 |
| Core EBITDA Growth(%) | 1.35 | 11.69 | 7.47 | -18.92 | -2.83 |
| EBIT Growth(%) | -0.01 | 17.06 | 6.82 | -22.44 | -2.64 |
| PAT Growth(%) | -7.16 | 14.24 | 5.41 | -23.16 | 16.51 |
| EPS Growth(%) | -7.88 | 14.24 | 4.59 | -23.16 | 16.51 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.39 | 0.24 | 0.09 | 0.09 | 0.01 |
| Current Ratio(x) | 1.30 | 1.61 | 3.57 | 3.58 | 2.07 |
| Quick Ratio(x) | 0.98 | 1.26 | 3.05 | 3.03 | 1.65 |
| Interest Cover(x) | 8.83 | 13.54 | 22.73 | 36.56 | 41.48 |
| Total Debt/Mcap(x) | 0.13 | 0.24 | 0.08 | 0.06 | 0.02 |
Compare Financial Ratios of peers of BHARAT PARENTERALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BHARAT PARENTERALS | ₹991.1 Cr | 1.2% | -10.1% | 136.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,992.0 Cr | -3.3% | -5.3% | 66.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,498.0 Cr | 1.6% | 8.7% | 76.4% | Stock Analytics | |
| CIPLA | ₹127,968.0 Cr | 7.2% | -2.4% | 29.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,796.0 Cr | -0.6% | -4.5% | 17.7% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹101,056.0 Cr | 0.2% | -5% | 74.5% | Stock Analytics | |
BHARAT PARENTERALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BHARAT PARENTERALS | 1.2% |
-10.1% |
136.7% |
| SENSEX | -1.5% |
-4.5% |
23.3% |
You may also like the below Video Courses
